Acute Myeloid Leukemia Cost In Hamburg

Acute Myeloid Leukemia, abbreviated as AML, is a type of blood cancer. Inside your bones, there's a place that makes blood cells. In AML, this place messes up and makes bad, immature white blood cells that grow too fast. These harmful cells take space away from good blood cells. This can make you feel exhausted because you lack healthy red blood cells. You might also bleed or bruise easily because there aren't enough platelets. And your body can't fight off infections as well because there are too few good white blood cells.

The treatment of acute myeloid leukemia includes:

• Induction Chemotherapy: The initial phase of AML treatment involves induction chemotherapy. This entails the administration of intensive chemotherapy regimens, often combining anthracycline and cytarabine drugs. The goal is to induce a complete remission, characterized by the absence of leukemia cells in the bone marrow and peripheral blood.
• Consolidation Therapy: Following induction therapy, patients typically undergo consolidation therapy. This phase aims to eliminate residual leukemia cells that may not have been eradicated during induction. Consolidation therapy can involve additional rounds of chemotherapy or, in select cases, stem cell transplantation.
• Stem Cell Transplants: Allogeneic stem cell transplantation is considered in high-risk AML cases or when the disease relapses. This procedure involves infusing healthy stem cells, often from donors, to replace the diseased bone marrow. It offers the potential for a cure by establishing a new, leukemia-free blood and immune system.
• Targeted Therapies: Recent advances in AML treatment include the development of targeted therapies like tyrosine kinase inhibitors (e.g., midostaurin) for specific genetic mutations like FLT3-ITD. These drugs are used alongside or following chemotherapy to target particular molecular abnormalities within leukemia cells.